NovaBridge Biosciences (NBP) Other Non-Current Liabilities (2018 - 2025)

NovaBridge Biosciences (NBP) has 7 years of Other Non-Current Liabilities data on file, last reported at $512000.0 in Q4 2025.

• Other Non-Current Liabilities for Q4 2025 came in at $512000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $512000.0 (changed N/A YoY), and the FY2025 annual result was $512000.0, changed N/A from the prior year.
• Other Non-Current Liabilities advanced to $512000.0 in Q4 2025 per NBP's latest filing, from -$106000.0 in the prior quarter.
• Over five years, Other Non-Current Liabilities peaked at $2.3 billion in Q4 2021 and troughed at -$147000.0 in Q2 2022.
• A 5-year average of $261.8 million and a median of $960000.0 in 2021 frame the typical range for Other Non-Current Liabilities.
• The sharpest annual moves came in 2021 and 2022: Other Non-Current Liabilities jumped 172378.56% in 2021, then slumped 115.31% in 2022.
• A 5-year view of Other Non-Current Liabilities shows it stood at $2.3 billion in 2021, then sank by 99.9% to $2.4 million in 2022, then jumped by 305.67% to $9.7 million in 2023, then plunged by 101.1% to -$106000.0 in 2024, then soared by 583.02% to $512000.0 in 2025.
• Business Quant data shows NBP's Other Non-Current Liabilities at $512000.0 in Q4 2025, -$106000.0 in Q3 2024, and -$106000.0 in Q2 2024.